GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa)

 TNR6A_HUMAN             Reviewed;        1962 AA.
Q8NDV7; C9JAR8; O15408; Q658L5; Q6NVB5; Q8NEZ0; Q8TBT8; Q8TCR0;
Q9NV59; Q9P268;
29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
18-MAY-2010, sequence version 2.
13-FEB-2019, entry version 170.
RecName: Full=Trinucleotide repeat-containing gene 6A protein;
AltName: Full=CAG repeat protein 26;
AltName: Full=EMSY interactor protein;
AltName: Full=GW182 autoantigen;
Short=Protein GW1;
AltName: Full=Glycine-tryptophan protein of 182 kDa;
Name=TNRC6A; Synonyms=CAGH26, KIAA1460, TNRC6;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), RNA-BINDING, TISSUE
SPECIFICITY, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
TISSUE=Cervix carcinoma;
PubMed=11950943; DOI=10.1091/mbc.01-11-0544;
Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K.,
Fritzler M.J.;
"A phosphorylated cytoplasmic autoantigen, GW182, associates with a
unique population of human mRNAs within novel cytoplasmic speckles.";
Mol. Biol. Cell 13:1338-1351(2002).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
Hughes-Davies L.;
"Candidate EMSY interactor protein.";
Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
SEQUENCE [LARGE SCALE MRNA] OF 861-1962 (ISOFORM 6).
TISSUE=Kidney, and Stomach;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15616553; DOI=10.1038/nature03187;
Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
Rubin E.M., Pennacchio L.A.;
"The sequence and analysis of duplication-rich human chromosome 16.";
Nature 432:988-994(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
SEQUENCE [LARGE SCALE MRNA] OF 1515-1962.
TISSUE=Kidney, and PNS;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-157 (ISOFORM 5).
TISSUE=Brain;
PubMed=9225980; DOI=10.1007/s004390050476;
Margolis R.L., Abraham M.R., Gatchell S.B., Li S.-H., Kidwai A.S.,
Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
"cDNAs with long CAG trinucleotide repeats from human brain.";
Hum. Genet. 100:114-122(1997).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-1962.
TISSUE=Brain;
PubMed=10819331; DOI=10.1093/dnares/7.2.143;
Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
"Prediction of the coding sequences of unidentified human genes. XVII.
The complete sequences of 100 new cDNA clones from brain which code
for large proteins in vitro.";
DNA Res. 7:143-150(2000).
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1522-1962.
TISSUE=Ovarian carcinoma;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[9]
AUTOANTIGENIC EPITOPE MAPPING.
PubMed=14598044; DOI=10.1007/s00109-003-0495-y;
Eystathioy T., Chan E.K.L., Takeuchi K., Mahler M., Luft L.M.,
Zochodne D.W., Fritzler M.J.;
"Clinical and serological associations of autoantibodies to GW bodies
and a novel cytoplasmic autoantigen GW182.";
J. Mol. Med. 81:811-818(2003).
[10]
SUBCELLULAR LOCATION.
PubMed=13130130; DOI=10.1261/rna.5810203;
Eystathioy T., Jakymiw A., Chan E.K.L., Seraphin B., Cougot N.,
Fritzler M.J.;
"The GW182 protein colocalizes with mRNA degradation associated
proteins hDcp1 and hLSm4 in cytoplasmic GW bodies.";
RNA 9:1171-1173(2003).
[11]
SUBCELLULAR LOCATION.
PubMed=15494374; DOI=10.1242/jcs.01477;
Yang Z., Jakymiw A., Wood M.R., Eystathioy T., Rubin R.L.,
Fritzler M.J., Chan E.K.L.;
"GW182 is critical for the stability of GW bodies expressed during the
cell cycle and cell proliferation.";
J. Cell Sci. 117:5567-5578(2004).
[12]
SUBCELLULAR LOCATION.
PubMed=15908945; DOI=10.1038/ncb1265;
Sen G.L., Blau H.M.;
"Argonaute 2/RISC resides in sites of mammalian mRNA decay known as
cytoplasmic bodies.";
Nat. Cell Biol. 7:633-636(2005).
[13]
FUNCTION, INTERACTION WITH AGO2, AND SUBCELLULAR LOCATION.
PubMed=16284623; DOI=10.1038/ncb1333;
Liu J., Rivas F.V., Wohlschlegel J., Yates J.R. III, Parker R.,
Hannon G.J.;
"A role for the P-body component GW182 in microRNA function.";
Nat. Cell Biol. 7:1261-1266(2005).
[14]
FUNCTION, INTERACTION WITH AGO2, ASSOCIATION WITH SIRNA, AND
SUBCELLULAR LOCATION.
PubMed=16284622; DOI=10.1038/ncb1334;
Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
Fritzler M.J., Chan E.K.L.;
"Disruption of GW bodies impairs mammalian RNA interference.";
Nat. Cell Biol. 7:1267-1274(2005).
[15]
ERRATUM.
Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
Fritzler M.J., Chan E.K.L.;
Nat. Cell Biol. 8:100-100(2006).
[16]
SUBCELLULAR LOCATION, AND ASSOCIATION WITH MICRORNA.
PubMed=16906129; DOI=10.1038/sj.embor.7400783;
Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J.,
Chan E.K.L.;
"Formation of GW bodies is a consequence of microRNA genesis.";
EMBO Rep. 7:904-910(2006).
[17]
FUNCTION.
PubMed=17671087; DOI=10.1101/gad.1566707;
Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
"Let-7 microRNA-mediated mRNA deadenylation and translational
repression in a mammalian cell-free system.";
Genes Dev. 21:1857-1862(2007).
[18]
ERRATUM.
Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
Genes Dev. 21:2509-2509(2007).
[19]
FUNCTION.
PubMed=17596515; DOI=10.1091/mbc.E07-01-0070;
Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
Chan E.K.L.;
"Small interfering RNA-mediated silencing induces target-dependent
assembly of GW/P bodies.";
Mol. Biol. Cell 18:3375-3387(2007).
[20]
ERRATUM.
Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
Chan E.K.L.;
Mol. Biol. Cell 18:4200-4200(2007).
[21]
FUNCTION, AND SUBCELLULAR LOCATION.
PubMed=19056672; DOI=10.1242/jcs.036905;
Li S., Lian S.L., Moser J.J., Fritzler M.L., Fritzler M.J., Satoh M.,
Chan E.K.L.;
"Identification of GW182 and its novel isoform TNGW1 as translational
repressors in Ago2-mediated silencing.";
J. Cell Sci. 121:4134-4144(2008).
[22]
IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH AGO2.
PubMed=18690212; DOI=10.1038/nature07186;
Qi H.H., Ongusaha P.P., Myllyharju J., Cheng D., Pakkanen O., Shi Y.,
Lee S.W., Peng J., Shi Y.;
"Prolyl 4-hydroxylation regulates Argonaute 2 stability.";
Nature 455:421-424(2008).
[23]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1470, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[24]
SUBCELLULAR LOCATION, AND INDUCTION.
PubMed=18946079; DOI=10.1091/mbc.E08-08-0796;
Jagannath A., Wood M.J.A.;
"Localization of double-stranded small interfering RNA to cytoplasmic
processing bodies is Ago2 dependent and results in up-regulation of
GW182 and Argonaute-2.";
Mol. Biol. Cell 20:521-529(2009).
[25]
FUNCTION, AND INTERACTION WITH AGO2.
PubMed=19304925; DOI=10.1261/rna.1448009;
Zipprich J.T., Bhattacharyya S., Mathys H., Filipowicz W.;
"Importance of the C-terminal domain of the human GW182 protein TNRC6C
for translational repression.";
RNA 15:781-793(2009).
[26]
INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4, SUBCELLULAR LOCATION, AND
MUTAGENESIS OF TRP-313; TRP-345; TRP-370; TRP-420 AND TRP-483.
PubMed=19324964; DOI=10.1261/rna.1229409;
Lian S.L., Li S., Abadal G.X., Pauley B.A., Fritzler M.J.,
Chan E.K.L.;
"The C-terminal half of human Ago2 binds to multiple GW-rich regions
of GW182 and requires GW182 to mediate silencing.";
RNA 15:804-813(2009).
[27]
INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4.
PubMed=19383768; DOI=10.1261/rna.1606309;
Lazzaretti D., Tournier I., Izaurralde E.;
"The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence
bound transcripts independently of Argonaute proteins.";
RNA 15:1059-1066(2009).
[28]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1585, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[29]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1869, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[30]
INTERACTION WITH CNOT1.
PubMed=21981923; DOI=10.1016/j.molcel.2011.09.007;
Braun J.E., Huntzinger E., Fauser M., Izaurralde E.;
"GW182 proteins directly recruit cytoplasmic deadenylase complexes to
miRNA targets.";
Mol. Cell 44:120-133(2011).
[31]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-739; SER-878; SER-991;
SER-1212; SER-1270 AND SER-1890, AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[32]
INTERACTION WITH ZC3H12A.
PubMed=26134560; DOI=10.1074/jbc.M114.635870;
Huang S., Liu S., Fu J.J., Tony Wang T., Yao X., Kumar A., Liu G.,
Fu M.;
"Monocyte chemotactic protein-induced protein 1 and 4 form a complex
but act independently in regulation of interleukin-6 mRNA
degradation.";
J. Biol. Chem. 290:20782-20792(2015).
[33]
INTERACTION WITH SND1.
PubMed=28546213; DOI=10.1126/science.aai9372;
Elbarbary R.A., Miyoshi K., Myers J.R., Du P., Ashton J.M., Tian B.,
Maquat L.E.;
"Tudor-SN-mediated endonucleolytic decay of human cell microRNAs
promotes G1/S phase transition.";
Science 356:859-862(2017).
[34]
INVOLVEMENT IN FAME6, AND TISSUE SPECIFICITY.
PubMed=29507423; DOI=10.1038/s41588-018-0067-2;
Ishiura H., Doi K., Mitsui J., Yoshimura J., Matsukawa M.K.,
Fujiyama A., Toyoshima Y., Kakita A., Takahashi H., Suzuki Y.,
Sugano S., Qu W., Ichikawa K., Yurino H., Higasa K., Shibata S.,
Mitsue A., Tanaka M., Ichikawa Y., Takahashi Y., Date H.,
Matsukawa T., Kanda J., Nakamoto F.K., Higashihara M., Abe K.,
Koike R., Sasagawa M., Kuroha Y., Hasegawa N., Kanesawa N., Kondo T.,
Hitomi T., Tada M., Takano H., Saito Y., Sanpei K., Onodera O.,
Nishizawa M., Nakamura M., Yasuda T., Sakiyama Y., Otsuka M., Ueki A.,
Kaida K.I., Shimizu J., Hanajima R., Hayashi T., Terao Y.,
Inomata-Terada S., Hamada M., Shirota Y., Kubota A., Ugawa Y., Koh K.,
Takiyama Y., Ohsawa-Yoshida N., Ishiura S., Yamasaki R., Tamaoka A.,
Akiyama H., Otsuki T., Sano A., Ikeda A., Goto J., Morishita S.,
Tsuji S.;
"Expansions of intronic TTTCA and TTTTA repeats in benign adult
familial myoclonic epilepsy.";
Nat. Genet. 50:581-590(2018).
-!- FUNCTION: Plays a role in RNA-mediated gene silencing by both
micro-RNAs (miRNAs) and short interfering RNAs (siRNAs). Required
for miRNA-dependent repression of translation and for siRNA-
dependent endonucleolytic cleavage of complementary mRNAs by
argonaute family proteins. As a scaffolding protein, associates
with argonaute proteins bound to partially complementary mRNAs,
and can simultaneously recruit CCR4-NOT and PAN deadenylase
complexes. {ECO:0000269|PubMed:16284622,
ECO:0000269|PubMed:16284623, ECO:0000269|PubMed:17596515,
ECO:0000269|PubMed:17671087, ECO:0000269|PubMed:19056672,
ECO:0000269|PubMed:19304925}.
-!- SUBUNIT: Interacts with AGO2 (PubMed:16284623, PubMed:16284622,
PubMed:18690212, PubMed:19304925, PubMed:19324964,
PubMed:19383768). Interacts with AGO1, AGO3 and AGO4
(PubMed:19324964, PubMed:19383768). Interacts with CNOT1; the
interaction is direct and mediates the association with the CCR4-
NOT complex (PubMed:21981923). Interacts with ZC3H12A
(PubMed:26134560). Interacts with SND1 (PubMed:28546213).
{ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623,
ECO:0000269|PubMed:18690212, ECO:0000269|PubMed:19304925,
ECO:0000269|PubMed:19324964, ECO:0000269|PubMed:19383768,
ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:26134560,
ECO:0000269|PubMed:28546213}.
-!- INTERACTION:
Q9UL18:AGO1; NbExp=5; IntAct=EBI-2269715, EBI-527363;
Q9UKV8:AGO2; NbExp=16; IntAct=EBI-2269715, EBI-528269;
Q9H9G7:AGO3; NbExp=3; IntAct=EBI-2269715, EBI-2267883;
Q9HCK5:AGO4; NbExp=4; IntAct=EBI-2269715, EBI-2269696;
A5YKK6:CNOT1; NbExp=2; IntAct=EBI-2269715, EBI-1222758;
P11940:PABPC1; NbExp=3; IntAct=EBI-2269715, EBI-81531;
Q58A45:PAN3; NbExp=2; IntAct=EBI-2269715, EBI-2513054;
Q15645:TRIP13; NbExp=3; IntAct=EBI-2269715, EBI-358993;
-!- SUBCELLULAR LOCATION: Cytoplasm, P-body
{ECO:0000269|PubMed:11950943, ECO:0000269|PubMed:13130130,
ECO:0000269|PubMed:15494374, ECO:0000269|PubMed:15908945,
ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623,
ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:18946079,
ECO:0000269|PubMed:19056672, ECO:0000269|PubMed:19324964}.
Note=Mammalian P-bodies are also known as GW bodies (GWBs).
{ECO:0000305}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=6;
Name=1; Synonyms=TNGW1;
IsoId=Q8NDV7-1; Sequence=Displayed;
Name=2;
IsoId=Q8NDV7-2; Sequence=VSP_013294;
Name=3;
IsoId=Q8NDV7-3; Sequence=VSP_037287, VSP_037288, VSP_037289;
Name=4;
IsoId=Q8NDV7-4; Sequence=VSP_013292;
Name=5;
IsoId=Q8NDV7-5; Sequence=VSP_013295;
Note=No experimental confirmation available.;
Name=6;
IsoId=Q8NDV7-6; Sequence=VSP_037288;
-!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11950943,
ECO:0000269|PubMed:29507423}.
-!- INDUCTION: By exogenous short interfering RNA (siRNA).
{ECO:0000269|PubMed:18946079}.
-!- DISEASE: Epilepsy, familial adult myoclonic, 6 (FAME6)
[MIM:618074]: A form of familial myoclonic epilepsy, a neurologic
disorder characterized by cortical hand tremors, myoclonic jerks
and occasional generalized or focal seizures with a non-
progressive or very slowly progressive disease course. Usually,
myoclonic tremor is the presenting symptom, characterized by
tremulous finger movements and myoclonic jerks of the limbs
increased by action and posture. In a minority of patients,
seizures are the presenting symptom. Some patients exhibit mild
cognitive impairment. FAME6 inheritance is autosomal dominant.
{ECO:0000269|PubMed:29507423}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- MISCELLANEOUS: Antibodies against TNRC6A are found in sera from
patients with Sjoegren syndrome (SS), ataxia and sensor neuropathy
diseases that developed autoantibodies against protein of the GWB
structure. Autoantibodies were mapped to the GW-rich mid-part, the
non-GW-rich region and the C-terminus of the protein.
-!- SIMILARITY: Belongs to the GW182 family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAA91899.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
Sequence=CAD28525.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AY035864; AAK62026.1; -; mRNA.
EMBL; AJ492221; CAD37348.1; -; mRNA.
EMBL; AL713750; CAD28525.2; ALT_INIT; mRNA.
EMBL; AL833757; CAH56236.1; -; mRNA.
EMBL; AC002565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC008731; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC024324; AAH24324.2; -; mRNA.
EMBL; BC068209; -; NOT_ANNOTATED_CDS; mRNA.
EMBL; U80739; AAB91438.1; -; mRNA.
EMBL; AB040893; BAA95984.1; -; mRNA.
EMBL; AK001773; BAA91899.1; ALT_INIT; mRNA.
CCDS; CCDS10624.2; -. [Q8NDV7-1]
CCDS; CCDS81959.1; -. [Q8NDV7-6]
RefSeq; NP_001317449.1; NM_001330520.1. [Q8NDV7-6]
RefSeq; NP_055309.2; NM_014494.2. [Q8NDV7-1]
RefSeq; XP_005255314.1; XM_005255257.4. [Q8NDV7-2]
RefSeq; XP_016878642.1; XM_017023153.1. [Q8NDV7-2]
UniGene; Hs.655057; -.
PDB; 5W6V; X-ray; 2.83 A; B=1073-1094.
PDBsum; 5W6V; -.
ProteinModelPortal; Q8NDV7; -.
SMR; Q8NDV7; -.
BioGrid; 118141; 49.
DIP; DIP-54489N; -.
ELM; Q8NDV7; -.
IntAct; Q8NDV7; 86.
MINT; Q8NDV7; -.
STRING; 9606.ENSP00000379144; -.
iPTMnet; Q8NDV7; -.
PhosphoSitePlus; Q8NDV7; -.
BioMuta; TNRC6A; -.
DMDM; 296452846; -.
EPD; Q8NDV7; -.
jPOST; Q8NDV7; -.
MaxQB; Q8NDV7; -.
PaxDb; Q8NDV7; -.
PeptideAtlas; Q8NDV7; -.
PRIDE; Q8NDV7; -.
ProteomicsDB; 73061; -.
ProteomicsDB; 73062; -. [Q8NDV7-2]
ProteomicsDB; 73063; -. [Q8NDV7-3]
ProteomicsDB; 73064; -. [Q8NDV7-4]
ProteomicsDB; 73065; -. [Q8NDV7-5]
ProteomicsDB; 73066; -. [Q8NDV7-6]
Ensembl; ENST00000315183; ENSP00000326900; ENSG00000090905. [Q8NDV7-6]
Ensembl; ENST00000395799; ENSP00000379144; ENSG00000090905. [Q8NDV7-1]
GeneID; 27327; -.
KEGG; hsa:27327; -.
UCSC; uc002dmm.4; human. [Q8NDV7-1]
CTD; 27327; -.
DisGeNET; 27327; -.
EuPathDB; HostDB:ENSG00000090905.17; -.
GeneCards; TNRC6A; -.
H-InvDB; HIX0012904; -.
H-InvDB; HIX0173209; -.
HGNC; HGNC:11969; TNRC6A.
HPA; HPA015305; -.
HPA; HPA017869; -.
MIM; 610739; gene.
MIM; 618074; phenotype.
neXtProt; NX_Q8NDV7; -.
OpenTargets; ENSG00000090905; -.
PharmGKB; PA36656; -.
eggNOG; ENOG410IF5S; Eukaryota.
eggNOG; ENOG41110AX; LUCA.
GeneTree; ENSGT00940000158180; -.
HOVERGEN; HBG062594; -.
InParanoid; Q8NDV7; -.
KO; K18412; -.
OMA; SPYFDKD; -.
OrthoDB; 50428at2759; -.
PhylomeDB; Q8NDV7; -.
TreeFam; TF329702; -.
Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
Reactome; R-HSA-2559585; Oncogene Induced Senescence.
Reactome; R-HSA-4086398; Ca2+ pathway.
Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
Reactome; R-HSA-8943723; Regulation of PTEN mRNA translation.
Reactome; R-HSA-8948700; Competing endogenous RNAs (ceRNAs) regulate PTEN translation.
Reactome; R-HSA-8986944; Transcriptional Regulation by MECP2.
Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
Reactome; R-HSA-9022692; Regulation of MECP2 expression and activity.
ChiTaRS; TNRC6A; human.
GeneWiki; TNRC6A; -.
GenomeRNAi; 27327; -.
PRO; PR:Q8NDV7; -.
Proteomes; UP000005640; Chromosome 16.
Bgee; ENSG00000090905; Expressed in 205 organ(s), highest expression level in cerebellar vermis.
ExpressionAtlas; Q8NDV7; baseline and differential.
Genevisible; Q8NDV7; HS.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
GO; GO:0035068; C:micro-ribonucleoprotein complex; IDA:UniProtKB.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0000932; C:P-body; IDA:MGI.
GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
GO; GO:0035195; P:gene silencing by miRNA; IMP:BHF-UCL.
GO; GO:0035278; P:miRNA mediated inhibition of translation; IDA:UniProtKB.
GO; GO:0010629; P:negative regulation of gene expression; TAS:Reactome.
GO; GO:0010628; P:positive regulation of gene expression; TAS:Reactome.
GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IBA:GO_Central.
GO; GO:0035194; P:posttranscriptional gene silencing by RNA; TAS:Reactome.
GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
CDD; cd12711; RRM_TNRC6A; 1.
Gene3D; 3.30.70.330; -; 1.
InterPro; IPR019486; Argonaute_hook_dom.
InterPro; IPR026805; GW182_M_dom.
InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
InterPro; IPR035979; RBD_domain_sf.
InterPro; IPR032226; TNRC6_PABC-bd.
InterPro; IPR033501; TNRC6A.
InterPro; IPR034924; TNRC6A_RRM.
PANTHER; PTHR13020:SF28; PTHR13020:SF28; 1.
Pfam; PF10427; Ago_hook; 1.
Pfam; PF12938; M_domain; 1.
Pfam; PF16608; TNRC6-PABC_bdg; 1.
SUPFAM; SSF54928; SSF54928; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; Coiled coil; Complete proteome;
Cytoplasm; Epilepsy; Phosphoprotein; Polymorphism; Reference proteome;
RNA-binding; RNA-mediated gene silencing; Translation regulation.
CHAIN 1 1962 Trinucleotide repeat-containing gene 6A
protein.
/FTId=PRO_0000081980.
DOMAIN 1781 1853 RRM.
REGION 1 932 Interaction with argonaute family
proteins.
REGION 254 503 Sufficient for interaction with AGO1,
AGO3 and AGO4.
REGION 270 346 Sufficient for interaction with AGO2.
REGION 318 399 Sufficient for interaction with AGO2.
REGION 340 439 Sufficient for interaction with AGO2.
REGION 409 495 Sufficient for interaction with AGO2.
REGION 502 751 Sufficient for interaction with AGO2.
REGION 566 1343 Sufficient for interaction with AGO1 and
AGO4.
REGION 1074 1144 Sufficient for interaction with AGO2.
REGION 1604 1622 PABPC1-interacting motif-2 (PAM2).
REGION 1670 1962 Sufficient for interaction with AGO2.
COILED 7 54 {ECO:0000255}.
COMPBIAS 93 127 Gln-rich.
COMPBIAS 192 365 Ser-rich.
MOD_RES 739 739 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 878 878 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 991 991 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 1212 1212 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 1270 1270 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 1470 1470 Phosphothreonine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 1585 1585 Phosphoserine.
{ECO:0000244|PubMed:19690332}.
MOD_RES 1869 1869 Phosphoserine.
{ECO:0000244|PubMed:20068231}.
MOD_RES 1890 1890 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
VAR_SEQ 1 1801 Missing (in isoform 4).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_013292.
VAR_SEQ 1 1232 Missing (in isoform 3).
{ECO:0000303|PubMed:17974005}.
/FTId=VSP_037287.
VAR_SEQ 1 253 Missing (in isoform 2).
{ECO:0000303|PubMed:11950943}.
/FTId=VSP_013294.
VAR_SEQ 1 54 MRELEAKATKDVERNLSRDLVQEEEQLMEEKKKKKDDKKKK
EAAQKKATEQKIK -> MAYFGGTLYWLIFSTPFLLLGL
(in isoform 5).
{ECO:0000303|PubMed:9225980}.
/FTId=VSP_013295.
VAR_SEQ 1280 1328 Missing (in isoform 3 and isoform 6).
{ECO:0000303|PubMed:17974005}.
/FTId=VSP_037288.
VAR_SEQ 1611 1962 Missing (in isoform 3).
{ECO:0000303|PubMed:17974005}.
/FTId=VSP_037289.
VARIANT 185 185 N -> K (in dbSNP:rs11639856).
/FTId=VAR_057251.
VARIANT 592 592 A -> T (in dbSNP:rs6497759).
/FTId=VAR_057252.
VARIANT 788 788 P -> S (in dbSNP:rs3803716).
/FTId=VAR_057253.
VARIANT 1268 1268 E -> K (in dbSNP:rs2112782).
/FTId=VAR_057254.
MUTAGEN 313 313 W->A: Does not impair interaction with
AGO2; when associated with A-345; A-370;
A-420 and A-483.
{ECO:0000269|PubMed:19324964}.
MUTAGEN 345 345 W->A: Does not impair interaction with
AGO2; when associated with A-313; A-370;
A-420 and A-483.
{ECO:0000269|PubMed:19324964}.
MUTAGEN 370 370 W->A: Does not impair interaction with
AGO2; when associated with A-313; A-345;
A-420 and A-483.
{ECO:0000269|PubMed:19324964}.
MUTAGEN 420 420 W->A: Does not impair interaction with
AGO2; when associated with A-313; A-345;
A-370 and A-483.
{ECO:0000269|PubMed:19324964}.
MUTAGEN 483 483 W->A: Does not impair interaction with
AGO2; when associated with A-313; A-345;
A-370 and A-420.
{ECO:0000269|PubMed:19324964}.
CONFLICT 31 34 KKKK -> TEKE (in Ref. 2; CAD37348).
{ECO:0000305}.
CONFLICT 1375 1375 V -> VV (in Ref. 3; CAD28525).
{ECO:0000305}.
CONFLICT 1704 1704 S -> F (in Ref. 8; BAA91899).
{ECO:0000305}.
SEQUENCE 1962 AA; 210297 MW; 963C054628E18592 CRC64;
MRELEAKATK DVERNLSRDL VQEEEQLMEE KKKKKDDKKK KEAAQKKATE QKIKVPEQIK
PSVSQPQPAN SNNGTSTATS TNNNAKRATA NNQQPQQQQQ QQQPQQQQPQ QQPQPQPQQQ
QPQQQPQALP RYPREVPPRF RHQEHKQLLK RGQHFPVIAA NLGSAVKVLN SQSESSALTN
QQPQNNGEVQ NSKNQSDINH STSGSHYENS QRGPVSSTSD SSTNCKNAVV SDLSEKEAWP
SAPGSDPELA SECMDADSAS SSESERNITI MASGNTGGEK DGLRNSTGLG SQNKFVVGSS
SNNVGHGSST GPWGFSHGAI ISTCQVSVDA PESKSESSNN RMNAWGTVSS SSNGGLNPST
LNSASNHGAW PVLENNGLAL KGPVGSGSSG INIQCSTIGQ MPNNQSINSK VSGGSTHGTW
GSLQETCESE VSGTQKVSFS GQPQNITTEM TGPNNTTNFM TSSLPNSGSV QNNELPSSNT
GAWRVSTMNH PQMQAPSGMN GTSLSHLSNG ESKSGGSYGT TWGAYGSNYS GDKCSGPNGQ
ANGDTVNATL MQPGVNGPMG TNFQVNTNKG GGVWESGAAN SQSTSWGSGN GANSGGSRRG
WGTPAQNTGT NLPSVEWNKL PSNQHSNDSA NGNGKTFTNG WKSTEEEDQG SATSQTNEQS
SVWAKTGGTV ESDGSTESTG RLEEKGTGES QSRDRRKIDQ HTLLQSIVNR TDLDPRVLSN
SGWGQTPIKQ NTAWDTETSP RGERKTDNGT EAWGSSATQT FNSGACIDKT SPNGNDTSSV
SGWGDPKPAL RWGDSKGSNC QGGWEDDSAA TGMVKSNQWG NCKEEKAAWN DSQKNKQGWG
DGQKSSQGWS VSASDNWGET SRNNHWGEAN KKSSSGGSDS DRSVSGWNEL GKTSSFTWGN
NINPNNSSGW DESSKPTPSQ GWGDPPKSNQ SLGWGDSSKP VSSPDWNKQQ DIVGSWGIPP
ATGKPPGTGW LGGPIPAPAK EEEPTGWEEP SPESIRRKME IDDGTSAWGD PSKYNYKNVN
MWNKNVPNGN SRSDQQAQVH QLLTPASAIS NKEASSGSGW GEPWGEPSTP ATTVDNGTSA
WGKPIDSGPS WGEPIAAASS TSTWGSSSVG PQALSKSGPK SMQDGWCGDD MPLPGNRPTG
WEEEEDVEIG MWNSNSSQEL NSSLNWPPYT KKMSSKGLSG KKRRRERGMM KGGNKQEEAW
INPFVKQFSN ISFSRDSPEE NVQSNKMDLS GGMLQDKRME IDKHSLNIGD YNRTVGKGPG
SRPQISKESS MERNPYFDKD GIVADESQNM QFMSSQSMKL PPSNSALPNQ ALGSIAGLGM
QNLNSVRQNG NPSMFGVGNT AAQPRGMQQP PAQPLSSSQP NLRAQVPPPL LSPQVPVSLL
KYAPNNGGLN PLFGPQQVAM LNQLSQLNQL SQISQLQRLL AQQQRAQSQR SVPSGNRPQQ
DQQGRPLSVQ QQMMQQSRQL DPNLLVKQQT PPSQQQPLHQ PAMKSFLDNV MPHTTPELQK
GPSPINAFSN FPIGLNSNLN VNMDMNSIKE PQSRLRKWTT VDSISVNTSL DQNSSKHGAI
SSGFRLEESP FVPYDFMNSS TSPASPPGSI GDGWPRAKSP NGSSSVNWPP EFRPGEPWKG
YPNIDPETDP YVTPGSVINN LSINTVREVD HLRDRNSGSS SSLNTTLPST SAWSSIRASN
YNVPLSSTAQ STSARNSDSK LTWSPGSVTN TSLAHELWKV PLPPKNITAP SRPPPGLTGQ
KPPLSTWDNS PLRIGGGWGN SDARYTPGSS WGESSSGRIT NWLVLKNLTP QIDGSTLRTL
CMQHGPLITF HLNLPHGNAL VRYSSKEEVV KAQKSLHMCV LGNTTILAEF ASEEEISRFF
AQSQSLTPSP GWQSLGSSQS RLGSLDCSHS FSSRTDLNHW NGAGLSGTNC GDLHGTSLWG
TPHYSTSLWG PPSSSDPRGI SSPSPINAFL SVDHLGGGGE SM


Related products :

Catalog number Product name Quantity
EIAAB43358 CAG repeat protein 26,CAGH26,EMSY interactor protein,Glycine-tryptophan protein of 182 kDa,GW182 autoantigen,Homo sapiens,Human,KIAA1460,Protein GW1,TNRC6,TNRC6A,Trinucleotide repeat-containing gene 6
EIAAB43470 CAG trinucleotide repeat-containing gene F9 protein,CAGF9,Homo sapiens,Human,TNRC9,TOX high mobility group box family member 3,TOX3,Trinucleotide repeat-containing gene 9 protein
EIAAB43279 CAGL79,Homo sapiens,Human,KIAA1856,Long CAG trinucleotide repeat-containing gene 79 protein,TNRC18,Trinucleotide repeat-containing gene 18 protein
EIAAB08269 CNPY3,CTG repeat protein 4a,CTG4A,ERDA5,Expanded repeat-domain protein CAG_CTG 5,Homo sapiens,HSPC084,Human,PRAT4A,Protein associated with TLR4,Protein canopy homolog 3,TNRC5,Trinucleotide repeat-cont
18-003-42427 Forkhead box protein P2 - CAG repeat protein 44; Trinucleotide repeat-containing gene 10 protein Polyclonal 0.05 mg Aff Pur
EIAAB13053 CAG repeat protein 32,CAGH32,Domino homolog,E1A-binding protein p400,EP400,hDomino,Homo sapiens,Human,KIAA1498,KIAA1818,p400 kDa SWI2_SNF2-related protein,TNRC12,Trinucleotide repeat-containing gene 1
EIAAB47428 CAG repeat protein 1,CAGH1,CAS-interacting zinc finger protein,CIZ,Homo sapiens,Human,NMP4,Nuclear matrix protein 4,Nuclear matrix transcription factor 4,TNRC1,Trinucleotide repeat-containing gene 1 p
EIAAB08271 Cnpy3,Mouse,Mus musculus,Prat4a,Protein associated with Tlr4,Protein canopy homolog 3,Tnrc5,Trinucleotide repeat-containing gene 5 protein
EIAAB30592 Gigyf2,GRB10-interacting GYF protein 2,Kiaa0642,Mouse,Mus musculus,PERQ amino acid-rich with GYF domain-containing protein 2,Perq2,Tnrc15,Trinucleotide repeat-containing gene 15 protein
EIAAB30593 GIGYF2,GRB10-interacting GYF protein 2,Homo sapiens,Human,KIAA0642,PERQ amino acid-rich with GYF domain-containing protein 2,PERQ2,TNRC15,Trinucleotide repeat-containing gene 15 protein
EIAAB08270 CNPY3,Pig,Protein canopy homolog 3,Sus scrofa,TNRC5,Trinucleotide repeat-containing gene 5 protein
EIAAB14615 Afh,Fbl3a,F-box and leucine-rich repeat protein 3A,F-box_LRR-repeat protein 3,F-box_LRR-repeat protein 3A,Fbxl3,Fbxl3a,Mouse,Mus musculus,Ovtm,Protein after-hours,Protein overtime
EIAAB44425 DCRR1,E3 ubiquitin-protein ligase TTC3,Homo sapiens,Human,Protein DCRR1,RING finger protein 105,RNF105,Tetratricopeptide repeat protein 3,TPR repeat protein 3,TPR repeat protein D,TPRD,TTC3
EIAAB43278 Kiaa1856,Mouse,Mus musculus,Tnrc18,Trinucleotide repeat-containing gene 18 protein,Zfp469,Zinc finger protein 469
EIAAB46451 Dd57,Mouse,Mus musculus,WD repeat-containing protein 8,WD repeat-containing protein antisense to TP73 gene,WD repeat-containing protein WRAP73,Wdr8,Wrap73
EIAAB46450 Homo sapiens,Human,WD repeat-containing protein 8,WD repeat-containing protein antisense to TP73 gene,WD repeat-containing protein WRAP73,WDR8,WRAP73
25-655 TNRC6A is a member of the trinucleotide repeat containing 6 protein family. The protein functions in post-transcriptional gene silencing through the RNA interference (RNAi) and microRNA pathways. The 0.05 mg
EIAAB46198 Big,Big3,BMP2-induced 3-kb gene protein,Mouse,Mus musculus,WD repeat-containing protein 5,WD repeat-containing protein BIG-3,Wdr5
EIAAB44454 Homo sapiens,Human,Tetratricopeptide repeat protein 7B,Tetratricopeptide repeat protein 7-like-1,TPR repeat protein 7B,TPR repeat protein 7-like-1,TTC7B,TTC7L1
EIAAB46135 Bromodomain and WD repeat-containing protein 2,BRWD2,Homo sapiens,Human,KIAA1351,WD repeat-containing protein 11,WD repeat-containing protein 15,WDR11,WDR15
EIAAB46365 Homo sapiens,Human,WD repeat domain phosphoinositide-interacting protein 3,WD repeat-containing protein 45-like,WDR45L,WDR45-like protein,WIPI3,WIPI-3,WIPI49-like protein
EIAAB14621 FBL4,FBL5,F-box and leucine-rich repeat protein 5,F-box protein FBL4_FBL5,F-box_LRR-repeat protein 5,FBXL5,FLR1,Homo sapiens,Human,p45SKP2-like protein
EIAAB44421 Homo sapiens,Human,Protein TBPP2A,Testis development protein NYD-SP14,Tetratricopeptide repeat protein 29,TPR repeat protein 29,TTC29
18-003-43690 Guanine nucleotide-binding protein subunit beta-like protein 1 - G protein subunit beta-like protein 1; WD40 repeat-containing protein deleted in VCFS; Protein WDVCF; WD repeat-containing protein 14; 0.1 mg Protein A
E0286b Mouse ELISA Kit FOR Trinucleotide repeat-containing gene 6C protein 96T

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1659: Glycine, serine and threonine metabolism
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining
WP1678: Nucleotide excision repair

Related Genes :
[TNRC6A CAGH26 KIAA1460 TNRC6] Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa)
[gw GW182 CG31992] Protein Gawky
[TNRC6C KIAA1582] Trinucleotide repeat-containing gene 6C protein
[gag-pro-pol] Gag-Pro-Pol polyprotein (Pr180) [Cleaved into: Matrix protein p10; Phosphorylated protein pp24; Phosphorylated protein pp18; p12; Capsid protein p27; Nucleocapsid protein-dUTPase (NC-dUTPase) (EC 3.6.1.23); Protease 17 kDa (EC 3.4.23.-); Protease 13 kDa (EC 3.4.23.-); G-patch peptide; Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[KRT6A K6A KRT6D] Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)
[KDM6A UTX] Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)
[gag-pro] Gag-Pro polyprotein (Pr95) [Cleaved into: Matrix protein p10; Phosphorylated protein pp24; Phosphorylated protein pp18; p12; Capsid protein p27; Nucleocapsid protein-dUTPase (NC-dUTPase) (EC 3.6.1.23); Protease 17 kDa (EC 3.4.23.-); Protease 13 kDa (EC 3.4.23.-); G-patch peptide]
[] Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
[Kdm6a Utx] Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein)
[LINGO1 LERN1 LRRN6A UNQ201/PRO227] Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A)
[Krt6a Ker2 Krt2-6 Krt2-6a Krt6] Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Keratin-6-alpha) (mK6-alpha) (Keratin-6A) (K6A)
[ACTL6A BAF53 BAF53A INO80K] Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)
[Actl6a Actl6 Baf53a] Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A)
[RPT5B TBP1 At1g09100 F7G19.2] 26S proteasome regulatory subunit 6A homolog B (26S proteasome AAA-ATPase subunit RPT5b) (Proteasome 26S subunit 6A homolog B) (Regulatory particle triple-A ATPase subunit 5b) (Tat-binding protein 1 homolog B) (TBP-1 homolog B)
[AGO2 EIF2C2] Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)
[RPT5A ATS6A.2 TBP1 At3g05530 F22F7.1] 26S proteasome regulatory subunit 6A homolog A (26S proteasome AAA-ATPase subunit RPT5a) (Proteasome 26S subunit 6A homolog A) (Regulatory particle triple-A ATPase subunit 5a) (Tat-binding protein 1 homolog A) (TBP-1 homolog A)
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[Sema6a Semaq] Semaphorin-6A (Semaphorin Q) (Sema Q) (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1)
[SEMA6A KIAA1368 SEMAQ] Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1)
[PSMC3 TBP1] 26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)
[NHP6A NHPA YPR052C YP9499.09C] Non-histone chromosomal protein 6A
[PARD6A PAR6A] Partitioning defective 6 homolog alpha (PAR-6) (PAR-6 alpha) (PAR-6A) (PAR6C) (Tax interaction protein 40) (TIP-40)
[gag] Gag polyprotein (Core polyprotein) (Pr78) [Cleaved into: Matrix protein p10; Phosphorylated protein pp24; Phosphorylated protein pp18; p12; Capsid protein p27; Nucleocapsid protein p14; p4]
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[Gpm6a M6a] Neuronal membrane glycoprotein M6-a (M6a)
[PAN3] PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3)
[Ago2 Eif2c2] Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Golgi ER protein 95 kDa) (GERp95) (Protein slicer)
[] Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 6a (BPP-6a); Bradykinin-potentiating peptide 10a (BPP-10a) (Bradykinin-potentiating peptide IV-1-A) (BPPIV-1-A) (Bradykinin-potentiating peptide V-8); Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide III-1-A) (III-1-A) (Bradykinin-potentiating peptide V-9); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide IV-1-Bbeta) (BPP IV-1-Bbeta) (Bradykinin-potentiating peptide V-7); Bradykinin-potentiating peptide 10c-F (BPP-10c-F); Bradykinin-potentiating peptide 11b (BPP-11b) (Bradykinin-potentiating peptide IIa) (BPP-IIa); Bradykinin-potentiating peptide IIb (BPP-IIb); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)]
[tsaD gcp ygjD b3064 JW3036] tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaD) (tRNA threonylcarbamoyladenosine biosynthesis protein TsaD)

Bibliography :
?>